Is InVitae Corp (NVTA) A Good Stock To Buy?

Page 1 of 2

Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. Many hedge funds, like Paul Singer’s Elliott Management, are pretty secretive, but we can still get some insights by analyzing their quarterly 13F filings. One of the most fertile grounds for large abnormal returns is hedge funds’ most popular small-cap picks, which are not so widely followed and often trade at a discount to their intrinsic value. In this article we will check out hedge fund activity in another small-cap stock: InVitae Corp (NYSE:NVTA) .

InVitae Corp (NYSE:NVTA) shares didn’t see a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 8 hedge funds’ portfolios at the end of the third quarter of 2016. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as First Connecticut Bancorp Inc (NASDAQ:FBNK), Gafisa SA (ADR) (NYSE:GFA), and Silicon Graphics International Corp (NASDAQ:SGI) to gather more data points.

Follow Invitae Corp (NYSE:NVTA)

We care about hedge fund sentiment because historically hedge funds’ stock picks delivered strong risk adjusted returns. There are certain segments of the market where hedge funds’ stock picks performed much better than its benchmarks. For instance, the 30 most popular mid-cap stocks among the best performing hedge funds returned 18% over the last 12 months outpacing S&P 500 Index by more than 10 percentage points. We developed this strategy 2.5 years ago and started sharing its picks in our quarterly newsletter. It bested the S&P 500 Index ETFs by delivering a solid 39% vs. 22% gain for its benchmarks.

gene, dna, organism, microarray, health, green, life, human genome, biotechnology, genetic diseases, disease, molecular biology, modern medical, micro structure,

Yang Nan/Shutterstock.com

Now, we’re going to take a gander at the key action surrounding InVitae Corp (NYSE:NVTA).

What have hedge funds been doing with InVitae Corp (NYSE:NVTA)?

At Q3’s end, a total of 8 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 0% from the previous quarter. The graph below displays the number of hedge funds with bullish position in NVTA over the last 5 quarters. So, let’s see which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

NVTA Chart

When looking at the institutional investors followed by Insider Monkey, Julian Baker and Felix Baker’s Baker Bros. Advisors has the biggest position in InVitae Corp (NYSE:NVTA), worth close to $57.4 million, amounting to 0.5% of its total 13F portfolio. The second most bullish fund manager is Camber Capital Management, led by Stephen DuBois, holding a $21.4 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Other peers that hold long positions include Kris Jenner, Gordon Bussard, Graham McPhail’s Rock Springs Capital Management, Jeremy Green’s Redmile Group and Samuel Isaly’s OrbiMed Advisors. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Page 1 of 2